These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


295 related items for PubMed ID: 15501746

  • 21. Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii.
    Ishimine T, Kawakami K, Nakamoto A, Saito A.
    Microbiol Immunol; 1995; 39(1):49-58. PubMed ID: 7783677
    [Abstract] [Full Text] [Related]

  • 22. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression.
    Qureshi MH, Garvy BA, Pomeroy C, Inayat MS, Oakley OR.
    Virus Res; 2005 Dec; 114(1-2):35-44. PubMed ID: 16002171
    [Abstract] [Full Text] [Related]

  • 23. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM, Warnock ML, Curtis JL, Sniezek MJ, Arraj-Peffer SM, Kaltreider HB, Shellito JE.
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [Abstract] [Full Text] [Related]

  • 24. The Interaction of Pneumocystis with the C-Type Lectin Receptor Mincle Exerts a Significant Role in Host Defense against Infection.
    Kottom TJ, Hebrink DM, Jenson PE, Nandakumar V, Wüthrich M, Wang H, Klein B, Yamasaki S, Lepenies B, Limper AH.
    J Immunol; 2017 May 01; 198(9):3515-3525. PubMed ID: 28298521
    [Abstract] [Full Text] [Related]

  • 25. IL-33 and M2a alveolar macrophages promote lung defense against the atypical fungal pathogen Pneumocystis murina.
    Nelson MP, Christmann BS, Werner JL, Metz AE, Trevor JL, Lowell CA, Steele C.
    J Immunol; 2011 Feb 15; 186(4):2372-81. PubMed ID: 21220696
    [Abstract] [Full Text] [Related]

  • 26. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii.
    Neese LW, Standing JE, Olson EJ, Castro M, Limper AH.
    J Immunol; 1994 May 01; 152(9):4549-56. PubMed ID: 7512599
    [Abstract] [Full Text] [Related]

  • 27. Interleukin-12 and host defense against murine Pneumocystis pneumonia.
    Ruan S, McKinley L, Zheng M, Rudner X, D'Souza A, Kolls JK, Shellito JE.
    Infect Immun; 2008 May 01; 76(5):2130-7. PubMed ID: 18332204
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Susceptibility and immune responses to Pneumocystis carinii infection in different strains of mice by contagious transmission].
    An CL, Su XP, Harmsen AG.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002 May 01; 20(4):220-2. PubMed ID: 12568024
    [Abstract] [Full Text] [Related]

  • 32. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
    Paine R, Preston AM, Wilcoxen S, Jin H, Siu BB, Morris SB, Reed JA, Ross G, Whitsett JA, Beck JM.
    J Immunol; 2000 Mar 01; 164(5):2602-9. PubMed ID: 10679099
    [Abstract] [Full Text] [Related]

  • 33. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection.
    Qureshi MH, Harmsen AG, Garvy BA.
    J Immunol; 2003 Jan 15; 170(2):1002-9. PubMed ID: 12517967
    [Abstract] [Full Text] [Related]

  • 34. Immunopathogenesis of Pneumocystis carinii pneumonia.
    Gigliotti F, Wright TW.
    Expert Rev Mol Med; 2005 Nov 14; 7(26):1-16. PubMed ID: 16842636
    [Abstract] [Full Text] [Related]

  • 35. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection.
    Lund FE, Hollifield M, Schuer K, Lines JL, Randall TD, Garvy BA.
    J Immunol; 2006 May 15; 176(10):6147-54. PubMed ID: 16670323
    [Abstract] [Full Text] [Related]

  • 36. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species.
    Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, Scanlon ST, Fusaro T, Casey J, Hawgood S, Gow AJ, Beers MF.
    Infect Immun; 2004 Oct 15; 72(10):6002-11. PubMed ID: 15385504
    [Abstract] [Full Text] [Related]

  • 37. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response.
    Chen W, Havell EA, Gigliotti F, Harmsen AG.
    Infect Immun; 1993 Jan 15; 61(1):97-102. PubMed ID: 8418070
    [Abstract] [Full Text] [Related]

  • 38. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina.
    Rapaka RR, Ricks DM, Alcorn JF, Chen K, Khader SA, Zheng M, Plevy S, Bengtén E, Kolls JK.
    J Exp Med; 2010 Dec 20; 207(13):2907-19. PubMed ID: 21149550
    [Abstract] [Full Text] [Related]

  • 39. Numbers of alveolar macrophages are increased during Pneumocystis pneumonia in mice.
    Lasbury ME, Durant PJ, Lee CH.
    J Eukaryot Microbiol; 2003 Dec 20; 50 Suppl():637-8. PubMed ID: 14736195
    [No Abstract] [Full Text] [Related]

  • 40. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.
    Wang J, Gigliotti F, Bhagwat SP, George TC, Wright TW.
    PLoS Pathog; 2010 Aug 19; 6(8):e1001058. PubMed ID: 20808846
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.